by Jon Rappoport
January 19, 2014
Remember a researcher named Gilles-Eric Seralini, his 2012 GMO study, and the controversy that swirled around it?
He
fed rats GMOs, in the form of Monsanto's Roundup Ready corn, and they
developed tumors. Some died. The study was published in the journal,
Food and Chemical Toxicology. Pictures of the rats were published.
A
wave of biotech-industry criticism ensued. Pressure built. "Experts"
said the study was grossly unscientific, its methods were
unprofessional, and Seralini was biased against GMOs from the get-go.
Monsanto didn't like Seralini at all.
The journal which published the Seralini study caved in and retracted it.
Why?
Not because Seralini did anything unethical, not because he plagiarized
material, not because he was dishonest in any way, but because:
He
used rats which (supposedly) had an inherent tendency to develop tumors
(the Sprague-Dawley strain), and because he used too few rats (10).
That's it. Those were Seralini's errors.
Well,
guess what? Eight years prior to Seralini, Monsanto also did a
rat-tumor-GMO study and published it in the very same journal.
Monsanto's study showed there were no tumor problems in the rats. But
here's the explosive kicker. Monsanto used the same strain of rats that
Seralini did and same number of rats (10). And nobody complained about
it.
Michael Hansen, senior scientist at Consumer's Union, explains in an interview with Steve Curwood at loe.org:
"Well,
basically what Dr. Séralini did was he did the same feeding study that
Monsanto did and published in the same journal eight years prior, and in
that study, they [Monsanto] used the same number of rats, and the same
strain of rats, and came to a conclusion there was no [tumor] problem.
So all of a sudden, eight years later, when somebody [Seralini] does
that same experiment, only runs it for two years rather than just 90
days, and their data suggests there are problems, [then] all of a sudden
the number of rats is too small? Well, if it's too small to show that
there's a [tumor] problem, wouldn't it be too small to show there's no
problem? They already said there should be a larger study, and it turns
out the European Commission is spending 3 million Euros to actually do
that Séralini study again, run it for two years, use 50 or more rats and
look at the carcinogenicity. So they're actually going to do the
full-blown cancer study, which suggests that Séralini's work was
important, because you wouldn't follow it up with a 3 million Euro study
if it was a completely worthless study."
Boom.
I
can just hear Monsanto felons gibbering: "Well, we the biotech industry
people published our study. We used 10 rats and we used the
Sprague-Dawley strain. And that was fine. It was especially fine because
our study showed GMOs were safe. But then this guy Seralini comes along
and does the same study with the same kind of rat and same number of
rats, and he discovers tumors. That's not fine. That's very bad.
He...he...used the wrong rats...yeah...and he didn't use enough rats.
He's a faker. Well, I mean, we used the same kind of rat and same number
of rats, but when we did the experiment, we were Good, and Seralini was
Bad. Do you see?"
Yes, the mists are clearing and things are coming into focus.
Any comments, Monsanto? I'd be happy to pass them along to Michael Hansen.
The author of two explosive collections, THE MATRIX REVEALED and EXIT FROM THE MATRIX, Jon was a candidate for a US Congressional seat in the 29th District of California. He maintains a consulting practice for private clients, the purpose of which is the expansion of personal creative power.
Nominated for a Pulitzer Prize, he has worked as an investigative
reporter for 30 years, writing articles on politics, medicine, and
health for CBS Healthwatch, LA Weekly, Spin Magazine, Stern, and other
newspapers and magazines in the US and Europe. Jon has delivered
lectures and seminars on global politics, health, logic, and creative
power to audiences around the world. You can sign up for his free emails
at NoMoreFakeNews.com.
No comments:
Post a Comment